Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma-Reference-Cited by-同舟云学术

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma

Published:2001-05 Issue:7 Volume:37 Page:870-877
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Judson I,Radford J.A,Harris M,Blay J.-Y,van Hoesel Q,le Cesne A,van Oosterom A.T,Clemons M.J,Kamby C,Hermans C,Whittaker J,Donato di Paola E,Verweij J,Nielsen S

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Doxorubicin in relapsed soft tissue sarcoma;Blackledge;Eur. J. Cancer,1990

2. Cyclosphosphamide versus ifosfamide;Bramwell;Cancer Chemother. Pharmacol.,1993

3. Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas;Steward;J. Clin. Oncol.,1993

4. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas;Santoro;J. Clin. Oncol.,1995

5. Chemotherapy in the multidisciplinary approach to soft tissue sarcomcas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective;Venveij;Ann. Oncol.,1992

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells;Molecular Therapy: Oncology;2024-09

2. Progress in histology specific treatments in soft tissue sarcoma;Expert Review of Anticancer Therapy;2024-08-05

3. Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study;eClinicalMedicine;2024-07

4. Management of Soft Tissue Sarcoma;Soft Tissue Sarcoma and Leiomyoma - Diagnosis, Management, and New Perspectives;2024-05-17

5. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05